Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Alastair Judge bought 10 shares of the stock in a transaction dated Wednesday, February 11th. The shares were bought at an average price of GBX 2,342 per share, for a total transaction of £234.20.
Alastair Judge also recently made the following trade(s):
- On Tuesday, January 13th, Alastair Judge bought 12 shares of Johnson Matthey stock. The stock was bought at an average cost of GBX 2,321 per share, with a total value of £278.52.
Johnson Matthey Price Performance
Shares of JMAT stock opened at GBX 2,346 on Thursday. The company has a debt-to-equity ratio of 62.73, a current ratio of 1.45 and a quick ratio of 0.76. The firm’s 50-day moving average is GBX 2,235.95 and its two-hundred day moving average is GBX 2,069. Johnson Matthey PLC has a 12 month low of GBX 1,131 and a 12 month high of GBX 2,434. The company has a market capitalization of £3.93 billion, a PE ratio of -35.60, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95.
Wall Street Analysts Forecast Growth
Several brokerages have recently commented on JMAT. Panmure Gordon restated a “buy” rating and issued a GBX 2,370 price objective on shares of Johnson Matthey in a report on Monday, November 24th. Berenberg Bank decreased their price target on Johnson Matthey from GBX 2,100 to GBX 2,050 and set a “hold” rating on the stock in a research note on Tuesday, November 25th. Deutsche Bank Aktiengesellschaft raised their price target on Johnson Matthey from GBX 2,300 to GBX 2,400 and gave the stock a “buy” rating in a research report on Wednesday, January 21st. Finally, Citigroup boosted their price objective on Johnson Matthey from GBX 1,800 to GBX 2,100 and gave the company a “neutral” rating in a report on Tuesday, October 21st. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of GBX 2,268.
View Our Latest Stock Analysis on Johnson Matthey
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Further Reading
- Five stocks we like better than Johnson Matthey
- Is THIS the Next Big Money Rush?
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
- Washington knows what’s coming. Do you?
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
